BioCardia
BCDA
BCDA
26 hedge funds and large institutions have $3.1M invested in BioCardia in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
43% less capital invested
Capital invested by funds: $5.49M → $3.1M (-$2.38M)
Holders
26
Holding in Top 10
–
Calls
$78K
Puts
$29K
Top Buyers
| 1 | +$54K | |
| 2 | +$42K | |
| 3 | +$18K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.63K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.62K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$72K | |
| 3 | -$38.3K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3.81K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$775 |